サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1777459

市販後ファーマコビジランスと医療情報の世界市場

Post-Marketing Pharmacovigilance and Medical Information

出版日
ページ情報
英文 285 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
市販後ファーマコビジランスと医療情報の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 285 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市販後ファーマコビジランスと医療情報の世界市場は2030年までに9兆6,000億米ドルに達する見込み

2024年に6兆米ドルと推定される市販後ファーマコビジランスと医療情報の世界市場は、2030年には9兆6,000億米ドルに達し、分析期間2024-2030年のCAGRは8.3％で成長すると予測されます。本レポートで分析したセグメントの1つである自発報告サービスは、CAGR 10.1％を記録し、分析期間終了時には4兆2,000億米ドルに達すると予測されます。強化型ADRレポーティングサービスセグメントの成長率は、分析期間中CAGR 7.8%と推定されます。

米国市場は1兆6,000億米ドルと推定、中国はCAGR13.2％で成長予測

米国の市販後ファーマコビジランスと医療情報市場は、2024年には1兆6,000億米ドルに達すると推定されます。世界第2位の経済大国である中国は、2030年までに2兆1,000億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.1%と8.0%と予測されています。欧州では、ドイツがCAGR 5.6%で成長すると予測されています。

世界の市販後ファーマコビジランスと医療情報市場- 主要動向と促進要因まとめ

製薬業界で市販後ファーマコビジランスが不可欠な理由とは？

市販後ファーマコビジランス（PV）は、規制当局の承認後に医薬品の安全性と有効性を確保する上で重要な役割を果たし、実使用における医薬品の潜在的リスク、有害事象（AE）、長期的影響に対処します。臨床試験は初期の安全性データを提供する一方で、サンプルサイズ、患者の多様性、期間が限定されることが多く、市販後調査は稀な、遅延した、または予期せぬ副作用を検出するために不可欠です。FDA（米国）、EMA（欧州）、MHRA（英国）、PMDA（日本）などの規制機関は、製薬会社が医薬品のライフサイクルを通じてリスクを評価、報告、軽減できるよう、継続的な医薬品安全性監視を義務付けています。

生物製剤、遺伝子治療薬、個別化医薬品の複雑化により、高度なファーマコビジランス戦略の必要性が高まっています。市販後調査には、自発報告システム（SRS）、電子カルテ（EHR）モニタリング、能動的調査、ビッグデータ解析が含まれ、実世界での薬剤の性能を追跡します。さらに製薬会社は、医療従事者（HCP）、患者、規制当局に正確でエビデンスに基づいた回答を提供し、医薬品の安全性情報伝達におけるコンプライアンスと透明性を確保するために、医療情報（MI）サービスに依存しています。

技術の進歩は市販後ファーマコビジランスをどのように強化しているか？

人工知能（AI）、機械学習（ML）、ビッグデータ解析、自然言語処理（NLP）などの技術革新は、有害事象検出のスピード、精度、自動化を改善することで、ファーマコビジランスに革命をもたらしています。AIを活用したアルゴリズムは、電子カルテ、ソーシャルメディアでの議論、患者報告による転帰を分析し、従来の手作業によるレビュープロセスよりも効率的に、潜在的な安全性シグナルや新たな薬剤関連リスクを特定することができます。

もう一つの大きな進歩は、市販後安全性調査におけるリアルワールド・エビデンス（RWE）と電子カルテ（EHR）の統合です。製薬企業や規制当局は、より広範な患者集団における長期的な安全性結果、適応外使用のリスク、薬物-薬物相互作用を評価するために、RGlobal Industry Analystsの分析を活用するようになってきています。これらの洞察は、医薬品の表示更新、市場撤退、リスク軽減戦略に関するデータ主導の意思決定に役立ちます。

クラウドベースのファーマコビジランス・プラットフォームと自動化ツールは、症例管理、シグナル検出、規制当局への報告も強化しています。多くの企業がクラウドベースの有害事象（AE）管理システムを採用しており、リアルタイムの有害事象報告、自動化された症例処理、合理化された世界の安全性コンプライアンスを可能にしています。また、医薬品安全性データ管理におけるブロックチェーン技術の導入は、データの完全性、セキュリティ、トレーサビリティを向上させ、改ざん防止されたファーマコビジランス記録を保証しています。

ファーマコビジランスと医療情報サービスの拡大を促進する主な市場動向とは？

ファーマコビジランス業界を形成する最も重要な動向の1つは、規制当局による監視の強化とコンプライアンス要件の進化です。世界中の規制機関は、より厳しい報告スケジュール、透明性の義務付け、リスク最小化戦略を課しており、製薬会社は自動化されたAI主導のファーマコビジランスシステムの採用を余儀なくされています。ファーマコビジランス計画に関するICH E2EガイドラインとISO IDMP（Identification of Medicinal Products）標準の導入は、統合安全性データ管理プラットフォームへの投資をさらに促進しています。

患者中心のファーマコビジランスとデジタルヘルスモニタリングの台頭も大きな動向です。モバイルヘルス（mヘルス）、ウェアラブルデバイス、患者生成ヘルスデータ（PGHD）の拡大により、医薬品安全性モニタリングはより積極的かつリアルタイムになってきています。製薬会社は、継続的な安全性データを収集するために、スマートフォンアプリ、ウェアラブルバイオセンサー、オンライン患者登録の利用を増やしており、リスクの早期発見と個別化されたファーマコビジランス・アプローチを可能にしています。

ファーマコビジランスと医療情報サービスのCRO（医薬品開発業務受託機関）やBPO（ビジネス・プロセス・アウトソーシング）プロバイダーへのアウトソーシングも重要な動向です。有害事象（AE）症例報告、安全性シグナル評価、規制当局への申請件数の増加に伴い、多くの製薬企業が市販後の安全性業務を専門のPVサービスプロバイダーやテクノロジーベンダーにアウトソーシングするようになっています。このようなアウトソーシングモデルは、規制遵守とデータ主導の意思決定を確保しつつ、運用コストを削減するのに役立っています。

市販後ファーマコビジランスと医療情報市場の成長を促す要因とは？

市販後ファーマコビジランスと医療情報市場の成長は、副作用（ADR）の発生率の増加、AIを活用した安全性監視の採用の増加、世界のファーマコビジランス規制の拡大など、いくつかの要因によってもたらされます。主な促進要因の1つは、新たに承認された医薬品、バイオシミラー、併用療法の数が増加していることであり、これらの医薬品は、長期的な安全性とファーマコビジランス法規の遵守を確保するために、市販後の継続的なモニタリングを必要としています。

もう1つの主な成長要因は、個別化医療と生物製剤の拡大であり、これらの医薬品は標的作用機序と患者固有の治療反応により、独自の安全性課題が存在します。細胞療法や遺伝子療法、免疫療法、高精度がん治療薬の採用拡大により、ゲノムおよびバイオマーカー主導のファーマコビジランスデータを統合する高度な安全性監視モデルに対する需要が高まっています。

医薬品安全性規制の世界の調和への注目が高まっていることも、市場を前進させています。規制機関は、有害事象の検出とシグナル管理を改善するために、標準化されたPVフレームワーク、デジタル報告ポータル、国境を越えた安全性データ共有について協力しています。製薬企業は、複数の法域で進化するファーマコビジランス法制に準拠する必要があり、自動コンプライアンス・プラットフォーム、規制情報ツール、安全性データベースの一元化への投資を促進しています。

さらに、新興市場におけるファーマコビジランスの台頭が市場拡大に寄与しています。中国、インド、ブラジル、韓国などの国々では、国レベルでのファーマコビジランスプログラムが強化されつつあり、国内で製造された医薬品と輸入された医薬品の両方に対して、より厳格な市販後調査が義務付けられています。地域に特化したPVの専門知識、多言語による安全性報告、地域特有のコンプライアンス・ソリューションに対する需要は、ファーマコビジランス・サービス・プロバイダーに新たな成長機会をもたらしています。

市販後安全性要件が厳しくなるにつれ、製薬企業はAIを活用した安全性監視、デジタルヘルスアナリティクス、患者中心のファーマコビジランスモデルへの投資を継続し、進化する世界ヘルスケアにおいて医薬品の安全性が最優先事項であり続けることを確実にするでしょう。

セグメント

サービスタイプ（自発報告サービス、強化型ADR報告サービス、ターゲット自発報告サービス、コホートイベントモニタリングサービス、EHRマイニングサービス）、エンドユーザー（病院エンドユーザー、研究機関エンドユーザー、その他エンドユーザー）

調査対象企業の例

  • 4C Pharma Solutions
  • Accenture Plc.
  • Allucent
  • APCER Life Sciences
  • ArisGlobal
  • ClinChoice
  • Cognizant Technology Solutions Corporation
  • Ergomed Plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences
  • ICON Plc
  • Indegene Limited
  • IQVIA
  • Labcorp Drug Development（formerly Covance）
  • Med Communications, Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development, Inc.（PPD）
  • Syneos Health
  • Veristat
  • Wipro Ltd.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32645

Global Post-Marketing Pharmacovigilance and Medical Information Market to Reach US$9.6 Trillion by 2030

The global market for Post-Marketing Pharmacovigilance and Medical Information estimated at US$6.0 Trillion in the year 2024, is expected to reach US$9.6 Trillion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Spontaneous Reporting Services, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$4.2 Trillion by the end of the analysis period. Growth in the Intensified ADR Reporting Services segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Trillion While China is Forecast to Grow at 13.2% CAGR

The Post-Marketing Pharmacovigilance and Medical Information market in the U.S. is estimated at US$1.6 Trillion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Trillion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Post-Marketing Pharmacovigilance and Medical Information Market - Key Trends & Drivers Summarized

Why Is Post-Marketing Pharmacovigilance Essential in the Pharmaceutical Industry?

Post-marketing pharmacovigilance (PV) plays a critical role in ensuring drug safety and efficacy after regulatory approval, addressing potential risks, adverse events (AEs), and long-term effects of pharmaceuticals in real-world use. While clinical trials provide initial safety data, they are often limited in sample size, patient diversity, and duration, making post-market surveillance essential for detecting rare, delayed, or unforeseen adverse reactions. Regulatory agencies such as the FDA (U.S.), EMA (Europe), MHRA (UK), and PMDA (Japan) mandate ongoing drug safety monitoring, ensuring that pharmaceutical companies assess, report, and mitigate risks throughout a drug’s lifecycle.

The increasing complexity of biologics, gene therapies, and personalized medicines has heightened the need for advanced pharmacovigilance strategies. Post-marketing surveillance involves spontaneous reporting systems (SRS), electronic health record (EHR) monitoring, active surveillance, and big data analytics to track real-world drug performance. Additionally, pharmaceutical companies rely on medical information (MI) services to provide accurate, evidence-based responses to healthcare professionals (HCPs), patients, and regulatory bodies, ensuring compliance and transparency in drug safety communication.

How Are Technological Advancements Enhancing Post-Marketing Pharmacovigilance?

Technological innovations such as artificial intelligence (AI), machine learning (ML), big data analytics, and natural language processing (NLP) are revolutionizing pharmacovigilance by improving the speed, accuracy, and automation of adverse event detection. AI-powered algorithms can analyze electronic medical records, social media discussions, and patient-reported outcomes to identify potential safety signals and emerging drug-related risks more efficiently than traditional manual review processes.

Another major advancement is the integration of real-world evidence (RWE) and electronic health records (EHRs) in post-marketing safety studies. Pharmaceutical companies and regulatory agencies are increasingly leveraging RWE analytics to assess long-term safety outcomes, off-label use risks, and drug-drug interactions in broader patient populations. These insights help in making data-driven decisions regarding drug labeling updates, market withdrawals, and risk mitigation strategies.

Cloud-based pharmacovigilance platforms and automation tools are also enhancing case management, signal detection, and regulatory reporting. Many companies are adopting cloud-based adverse event (AE) management systems, allowing for real-time adverse event reporting, automated case processing, and streamlined global safety compliance. The implementation of blockchain technology in drug safety data management is also improving data integrity, security, and traceability, ensuring tamper-proof pharmacovigilance records.

What Are the Key Market Trends Driving the Expansion of Pharmacovigilance and Medical Information Services?

One of the most significant trends shaping the pharmacovigilance industry is the increasing regulatory scrutiny and evolving compliance requirements. Regulatory agencies worldwide are imposing stricter reporting timelines, transparency mandates, and risk minimization strategies, compelling pharmaceutical companies to adopt automated and AI-driven pharmacovigilance systems. The implementation of ICH E2E guidelines on pharmacovigilance planning and ISO IDMP (Identification of Medicinal Products) standards is further driving investments in integrated safety data management platforms.

The rise of patient-centric pharmacovigilance and digital health monitoring is another major trend. With the expansion of mobile health (mHealth), wearable devices, and patient-generated health data (PGHD), drug safety monitoring is becoming more proactive and real-time. Pharmaceutical companies are increasingly using smartphone apps, wearable biosensors, and online patient registries to collect continuous safety data, allowing for early risk detection and personalized pharmacovigilance approaches.

Another key trend is the outsourcing of pharmacovigilance and medical information services to contract research organizations (CROs) and business process outsourcing (BPO) providers. The increasing volume of adverse event (AE) case reports, safety signal assessments, and regulatory filings has led many pharmaceutical companies to outsource post-marketing safety operations to specialized PV service providers and technology vendors. This outsourcing model helps reduce operational costs while ensuring regulatory compliance and data-driven decision-making.

What Factors Are Driving the Growth of the Post-Marketing Pharmacovigilance and Medical Information Market?

The growth in the post-marketing pharmacovigilance and medical information market is driven by several factors, including the increasing incidence of adverse drug reactions (ADRs), rising adoption of AI-driven safety surveillance, and the expansion of global pharmacovigilance regulations. One of the primary drivers is the rising number of newly approved drugs, biosimilars, and combination therapies, which require continuous post-market monitoring to ensure long-term safety and compliance with pharmacovigilance legislation.

Another key growth factor is the expansion of personalized medicine and biologics, which present unique safety challenges due to their targeted mechanisms of action and patient-specific treatment responses. The growing adoption of cell and gene therapies, immunotherapies, and precision oncology drugs has increased the demand for advanced safety surveillance models that integrate genomic and biomarker-driven pharmacovigilance data.

The increasing focus on global harmonization of drug safety regulations is also driving the market forward. Regulatory bodies are collaborating on standardized PV frameworks, digital reporting portals, and cross-border safety data sharing to improve adverse event detection and signal management. Pharmaceutical companies must comply with evolving pharmacovigilance legislation across multiple jurisdictions, driving investments in automated compliance platforms, regulatory intelligence tools, and centralized safety databases.

Additionally, the rise of pharmacovigilance in emerging markets is contributing to market expansion. Countries such as China, India, Brazil, and South Korea are strengthening their national pharmacovigilance programs, enforcing stricter post-market surveillance mandates for both locally manufactured and imported pharmaceutical products. The demand for localized PV expertise, multilingual safety reporting, and region-specific compliance solutions is creating new growth opportunities for pharmacovigilance service providers.

As post-marketing safety requirements become more stringent, pharmaceutical companies will continue to invest in AI-powered safety monitoring, digital health analytics, and patient-centric pharmacovigilance models, ensuring that drug safety remains a top priority in the evolving global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Post-Marketing Pharmacovigilance and Medical Information market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services, EHR Mining Services); End-Use (Hospitals End-Use, Research Organizations End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 4C Pharma Solutions
  • Accenture Plc.
  • Allucent
  • APCER Life Sciences
  • ArisGlobal
  • ClinChoice
  • Cognizant Technology Solutions Corporation
  • Ergomed Plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences
  • ICON Plc
  • Indegene Limited
  • IQVIA
  • Labcorp Drug Development (formerly Covance)
  • Med Communications, Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development, Inc. (PPD)
  • Syneos Health
  • Veristat
  • Wipro Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Post-Marketing Pharmacovigilance and Medical Information - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Regulatory Scrutiny on Post-Marketing Surveillance Boosts the Demand for Pharmacovigilance Services
    • Growing Focus on Patient Safety and Risk Management Strengthens the Case for Comprehensive Pharmacovigilance Programs
    • Shift Toward Real-Time Monitoring of Adverse Drug Reactions Accelerates Adoption of Advanced Pharmacovigilance Technologies
    • Integration of Artificial Intelligence and Machine Learning in Pharmacovigilance Enhances Data Analysis and Signal Detection
    • Expansion of Global Healthcare Markets and Pharmaceutical Products Drives Demand for Post-Marketing Surveillance Services
    • Post-Marketing Surveillance Becomes a Key Driver of Drug Approval and Market Access Strategies
    • Increased Investment in Automated Pharmacovigilance Systems Accelerates Market Growth
    • Rising Incidence of Drug-Related Side Effects Prompts Heightened Focus on Pharmacovigilance
    • Increased Adoption of Cloud-Based Solutions for Pharmacovigilance Data Management Expands Market Opportunities
    • Digital Transformation and Big Data Analytics Enhance the Efficiency and Accuracy of Post-Marketing Surveillance
    • Growing Global Health Concerns and Emerging Diseases Amplify the Need for Post-Marketing Surveillance in New Markets
    • Implementation of Advanced Medical Information Platforms Increases Access to Critical Drug Data and Enhances Patient Support
    • Increasing Patient Empowerment and Access to Health Information Drives the Growth of Medical Information Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Post-Marketing Pharmacovigilance and Medical Information Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Spontaneous Reporting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intensified ADR Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intensified ADR Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intensified ADR Reporting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Targeted Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Targeted Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Targeted Spontaneous Reporting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cohort Event Monitoring Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cohort Event Monitoring Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cohort Event Monitoring Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for EHR Mining Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for EHR Mining Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for EHR Mining Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION